BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19472270)

  • 1. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Savinainen JR; Käsnänen H; Xhaard H; Nevalainen T; Laitinen JT; Poso A; Leppänen J; Saario SM
    ChemMedChem; 2009 Aug; 4(8):1253-9. PubMed ID: 19472270
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
    Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
    J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
    Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
    Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.
    Kapanda CN; Muccioli GG; Labar G; Poupaert JH; Lambert DM
    J Med Chem; 2009 Nov; 52(22):7310-4. PubMed ID: 19883085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay.
    Muccioli GG; Labar G; Lambert DM
    Chembiochem; 2008 Nov; 9(16):2704-10. PubMed ID: 18855964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography assay with fluorescence detection for the evaluation of inhibitors against human recombinant monoacylglycerol lipase.
    Holtfrerich A; Makharadze T; Lehr M
    Anal Biochem; 2010 Apr; 399(2):218-24. PubMed ID: 20015447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
    Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
    J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.
    Feledziak M; Michaux C; Urbach A; Labar G; Muccioli GG; Lambert DM; Marchand-Brynaert J
    J Med Chem; 2009 Nov; 52(22):7054-68. PubMed ID: 19877691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
    Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover.
    Feaster SR; Lee K; Baker N; Hui DY; Quinn DM
    Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.
    Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ
    Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
    Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
    ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
    Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
    Morera L; Labar G; Ortar G; Lambert DM
    Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of on-target FAAH inhibitors.
    Deutsch DG
    Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.
    Patel JZ; Nevalainen TJ; Savinainen JR; Adams Y; Laitinen T; Runyon RS; Vaara M; Ahenkorah S; Kaczor AA; Navia-Paldanius D; Gynther M; Aaltonen N; Joharapurkar AA; Jain MR; Haka AS; Maxfield FR; Laitinen JT; Parkkari T
    ChemMedChem; 2015 Feb; 10(2):253-65. PubMed ID: 25504894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique.
    Savinainen JR; Yoshino M; Minkkilä A; Nevalainen T; Laitinen JT
    Anal Biochem; 2010 Apr; 399(1):132-4. PubMed ID: 20005861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.